Filters
Hikma launches Cefazolin for Injection, USP, in the US
Press Release, Product
Hikma expands impact in Canada with launches of new sterile injectable medicines
Press Release, Product
Hikma delivers a resilient underlying performance in 2022
Press Release, Financial Results
Hikma to present at 41st Annual J.P. Morgan Healthcare Conference
Press Release, Corporate
Hikma expands addiction therapy portfolio with the launch of Naloxone Hydrochloride Injection, USP, in prefilled syringe
Press Release, Product
Hikma and Celltrion Healthcare sign new exclusive licensing agreement for Vegzelma® for the Middle East and North Africa...
Press Release, Corporate
Hikma launches authorized generic of Xyrem® (sodium oxybate) in the US
Press Release, Product
Hikma and Junshi Biosciences sign exclusive licensing agreement for cancer treatment drug toripalimab for the Middle Eas...
Press Release, Product
Hikma launches Levothyroxine Sodium Injection in ready-to-use vials
Press Release, Product
Hikma Injectables Portugal site visit
Press Release, Corporate
Hikma and Celltrion Healthcare sign exclusive licensing agreement for ustekinumab for the Middle East and North Africa r...
Press Release, Corporate
Hikma reiterates full year segmental guidance, with strong momentum in Injectables and Branded
Press Release, Corporate
Hikma launches first prefilled syringe of Succinylcholine Chloride Injection, USP
Press Release, Product
Hikma appoints Deneen Vojta, M.D. as a Director
Press Release, Corporate